ABSTRACT: The basis for cognitive impairment in Duchenne muscular dystrophy (DMD) is not well understood but may be related to abnormal expression of dystrophin in brain. The aim of this study was to determine whether regional brain glucose metabolism is altered in children with DMD and whether such metabolic disturbances are localized to regions shown to be normally rich in dystrophin expression. Ten boys (mean age, 11.8 years) with DMD and 17 normal adults as a control group (mean age, 27.6 years) underwent 2-deoxy-2[
X-linked recessive disorder characterized by the lack of dystrophin, the protein product of the DMD gene. 43 Its overwhelming feature is progressive skeletal muscle weakness and degeneration resulting in early death. 31 Many patients with DMD show cognitive and behavioral impairments. 3, 18, 25 Before discovery of dystrophin, these abnormalities were thought to be secondary effects of a chronic somatic disorder. It has been recognized, however, that although dystrophin is most abundant in skeletal muscle, significant levels are also found in cardiac and brain tissue. 4, 19 At least seven separate promoters at the DMD gene locus code for nervous system transcripts of distinct dystrophin isoforms. 29 As dystrophin is not expressed in the brain of DMD patients, it has been hypothesized that this may be the basis for the central nervous system symptoms in DMD. 18, 19, 25 Although an early computed tomography study suggested mild cerebral atrophy in DMD patients, 42 cranial magnetic resonance imaging (MRI) studies did not reveal any significant structural brain alterations in DMD subjects 1 or in the mdx mouse model of DMD. 11 In contrast, functional neuroimaging studies have demonstrated a large variety of abnormalities in DMD and mdx brain. Increased cerebellar choline/N-acetylaspartate ratios and higher than normal concentrations of choline compounds were found by 1 H magnetic resonance spectroscopy (MRS) in DMD patients 34 and mdx mice, 40 suggesting gliosis or developmental abnormalities. Using 31 P MRS, increased ratios of inorganic phosphate to adenosine triphosphate and inorganic phosphate to phosphocreatine were reported in the cerebral cortex of DMD patients, suggesting possible mitochondrial impairment causing bioenergetic changes. 41 Recently, decreased levels of free glucose were found associated with increased cellular flux of 13 C through pathways of oxidative glucose metabolism in mdx mouse brain by MRS. 33 A previous study of four older children with DMD using 2-deoxy-2[
18 F]fluoro-Dglucose (FDG) positron emission tomography (PET) demonstrated cerebellar glucose hypometabolism and variable involvement of cortical associative areas 3 ; however, a low-resolution PET scanner was used in that study, and group analysis was not performed. In addition, the calculated regional glucose metabolic values did not represent precisely the examined anatomical regions, as circular regions of interest were drawn for cortical areas, and not all brain regions were addressed.
In the present study, we examined children with DMD and adult control subjects using FDG PET to determine the differences in pattern of regional brain glucose metabolism. For an accurate and objective data analysis, we applied statistical parametric mapping (SPM). An additional goal of this study was to evaluate the neuropsychological data in children with DMD.
MATERIALS AND METHODS

Subjects.
Ten boys (age range, 5.2-16.2 years; mean age, 11.8 years) with DMD were included in this study. All children had the typical features of DMD and elevated serum creatine kinase levels. Electromyography showed myopathic features and the diagnosis was confirmed by muscle biopsy in all children. All patients showed absent dystrophin immunoreactivity in muscle by Western blot analysis. DNA analysis was performed in seven patients and revealed deletions in the dystrophin gene in all of them.
All 35 On nonverbal intellectual testing, administration procedures were adapted for patients whose motor functioning was impaired to a degree judged to adversely influence their ability to perform on timed tests of nonverbal abilities. Adaptations were those advocated by Sattler. 35 To obtain normative neuroimaging data, we studied 17 normal adults (9 men and 8 women; age range, 21.1-38.2 years; mean age, 27.6 years). All control subjects had normal MRI and PET scans. None of the adults was taking any medication and none had a history of neurological or psychiatric disorder. Studies were performed in compliance with the regulations of Wayne State University Human Investigation Committee, and written informed consent of adult participants and parent or legal guardian of patients was obtained before all studies.
PET Scanning Procedure.
Subjects fasted for 4 h prior to the PET studies. A venous line was established for injection of FDG (0.143 mCi/kg) produced using a CTI RDS-11 cyclotron (Knoxville, Tennessee). External stimuli were minimized by dimming the lights and discouraging interaction, so that studies reflected the resting awake state during the uptake period (0 -30 min after injection). Sedation with intravenous pentobarbital or midazolam was used if necessary only after completion of the uptake period.
Scanning was performed using a CTI/Siemens EXACT/HR whole body positron tomograph. The scanner has a 15-cm field of view and generates 47 image planes with a slice thickness of 3.125 mm. The reconstructed image in-plane resolution obtained is 6.5 Ϯ 0.35 mm at full-width-at-half-maximum (FWHM) and 6.0 Ϯ 0.49 mm in the axial direction for the FDG PET (reconstruction parameters: Shepp-Logan filter with 1.1 cycles/cm cut-off frequency and Hanning filter with 0.20 cycles/pixel cut-off frequency). Calculated attenuation correction was performed as previously described. 2 
SPM Analysis.
Although the SPM analysis has been validated only for children over 6 years of age, 32 we included a 5.2-year-old patient in the analysis, as the orthogonal brain diameters (measured through the three Talairach reference lines [anterior commissure-posterior comissure, vertical and midline]) of this patient were not different from the same measures of the other nine patients who were above 6 years of age. To define objectively brain regions with abnormal glucose metabolism in the DMD patients, we assessed regionally specific differences between the patient group and the adult normal controls using linear contrasts. 16 The PET volumes were processed using the SPM96 module (Wellcome Department of Cognitive Neurology, Institute of Neurology, London, UK) incorporated in the MEDx software package (Sensor Systems, Inc., Sterling, Virginia) installed on an SGI Octane workstation (Silicon Graphics, Inc., Mountain View, California). Spatial normalization into standard stereotactic space 39 was performed using 12 affine parameters and a linear combination of threedimensional basis images to minimize the sum-ofsquares between an individual PET image volume and the PET image template. 15 The basis images used were those that make up the lowest-frequency components of a three-dimensional discrete cosine transform. 23 We used the default values of 4 ϫ 5 ϫ 4 basis functions and applied eight iterations. The matrix size of the PET image template provided with the SPM96 software was 91 ϫ 109 ϫ 91 voxels, with an isotropic voxel size of 2 mm 3 . In the process of spatial normalization, the PET image volumes were temporarily smoothed with a three-dimensional Gaussian kernel of 8 mm FWHM to match the resolution of the PET image template.
Following spatial normalization, all image volumes were smoothed with a three-dimensional Gaussian kernel of 12 mm FWHM. Our previous studies showed that this filter is adequate for the processing of pediatric brains. 32 The confounding effect of global activity was removed using proportional scaling. A Student's unpaired t-test based on two contrasts (group 1 minus group 2, and group 2 minus group 1) was applied to the data in each group testing. The resulting SPM(t) was transformed to a normal distribution, SPM(Z), and thresholded at P ϭ 0.002 (uncorrected). Only those regions of more than 50 voxels attaining a corrected P value of less than 0.05 were considered. The significance of each region was estimated using distributional approximations from the theory of Gaussian fields. 16 The SPM(Z) maps were analyzed using two corrected levels of statistical inference: a voxel level (Z), and a cluster level (k, Z). The voxel level represents the probability (corrected for multiple comparisons based on the number of resolution elements in the image volume) of observing a Z-score of "Z" or higher, whereas the cluster level represents the probability of observing a cluster size "k" or larger with a maximal Z-score of "Z" or higher. The corrected significance level was chosen as P Ͻ 0.05. The resulting significant differences in 3D image space were displayed collapsed into three orthogonal planes ("glass brain"). Regions of significant difference were overlaid on normalized T1-weighted images to facilitate correlation with anatomy. The Talairach coordinates 39 are given in millimeters describing the location of significant voxels; x defining the lateral displacement of this voxel from the midline (left ϭ negative), y defining the anteroposterior position relative to the anterior commissure (posterior ϭ negative), and z defining the vertical position relative to the line connecting the anterior and posterior commissure (down ϭ negative).
Statistical Analysis.
All statistical analyses were performed using the SPSS 10.0 statistical package (SPSS Inc., Chicago, Illinois). Associations between neuropsychological variables and age were analyzed via Pearson's product moment correlational analyses, corrected for multiple comparisons using a Bonferroni correction. Corrected P Ͻ 0.05 was considered to be significant.
RESULTS
SPM Analysis.
The analysis showed four clusters of decreased glucose metabolism in the children with DMD (Table 1) , and one cluster with marginal significance. The clusters included the medial temporal structures and cerebellum bilaterally and the sensorimotor area and lateral temporal cortex on the right side (Table 1 ; Figs. 1-3) . At the voxel level, significantly decreased glucose metabolism was found in the DMD group in the right postcentral and middle temporal gyri, uncus, and VIIIB cerebellar lobule, as well as in the left hippocampal gyrus and crus 1 cerebellar lobule (Table 1 ). In addition, there was a tendency for significance in the right hippocampus (Table 1) . No significant increases were found in the DMD group as compared with the normal controls.
Neuropsychological Evaluation. Group means for neuropsychological evaluation of DMD children are presented in Table 2 . The group neuropsychological profile revealed borderline global intellectual functioning, with low-average verbal intellectual and bor-derline nonverbal intellectual functioning. Expressive and receptive language fell in the average range, and visual memory functions were measured in the low-average range. Manual dexterity was impaired bilaterally. Measurement of behavioral functioning indicated borderline cognitive functioning and internalizing behavioral difficulties.
Correlational analyses between neuropsychological variables and age revealed no significant associations between age and any of the neuropsychological variables; however, trends in the direction of reduced manual dexterity for the dominant hand (r ϭ Ϫ0.874; P ϭ 0.06) and receptive language (r ϭ Ϫ0.937; P ϭ 0.072) were found in the older patients.
DISCUSSION
In the present study, we determined a regional pattern of brain glucose metabolism in children with DMD using the SPM data-analysis method. The ideal control group for pediatric SPM analysis would be an age-matched group of normal children; however, this is not possible because of ethical restraints. The rationale for using an adult control group is based on our previous studies showing similar overall patterns of brain glucose metabolism in childhood (Ͼ1 year of age) and adulthood, despite huge differences in the absolute rates of glucose utilization. 6, 7 We reasoned that if the regional pattern of glucose utilization is indeed fixed by 1 year of age, comparison of glucose PET scan using SPM, a technique that compares data that are normalized to the global mean, might be a useful approach for the study of pediatric disorders. Furthermore, SPM is used to compare patterns between groups and can be used to compare adult patterns with those of children older than 6 years of age. 32 Previous studies using this analytic approach in different pediatric neuropsychiatric conditions 5, 24, 32 provided considerably different results, and this supports the belief that the objective PET findings were related to the underlying disease rather than to developmental differences in regional brain glucose metabolism.
We found reduced regional brain glucose metabolism in children with DMD involving the sensorimotor area, temporal neocortex, medial temporal structures, and cerebellum. In normal brain, these areas are rich in dystrophin, which is restricted to postsynaptic membrane of neurons including neocortical pyramidal neurons (predominantly in deep frontal pyramidal layers), hippocampal CA regions, and the soma and dendritic regions of cerebellar Purkinje cells. 21, 26, 27, 29 In contrast, we did not find decreased glucose metabolism in subcortical gray matter structures and white matter where little or no dystrophin immunoreactivity has been identi- fied. 26, 27 This suggests an association between the pathological lack of dystrophin in regions normally abundant in dystrophin and presence of glucose hypometabolism in patients with DMD.
Our findings are partly consistent with the results of a previous FDG PET study on DMD subjects. 3 That study also showed cerebellar hypometabolism in all examined patients and a variable involvement of the frontal, parietal, temporal, occipital, and cerebellar cortical areas; however, the results of that study were based on individual analyses, whereas our findings reflect group differences and show abnormalities in several additional regions (e.g., medial temporal structures), indicating common brain structures that are functionally abnormal in DMD. Still, individual variations of abnormal glucose metabolism likely occur and can be related to, for example, genetic heterogeneity of the disease. This issue is not addressed by the present study and would require PET analysis of a larger patient population with wellcharacterized genetic abnormalities.
Our findings indicate more decreases in glucose metabolism in the right hemisphere than in the left. It is possible that the asymmetric involvement may be related to functional asymmetries in the male brain, whereas the female brain appears to show more symmetry. For example, there is evidence that language functions are more lateralized in men than in women. 38 Our findings in DMD patients suggesting increased susceptibility of the right hemisphere (in a disease of men) require further consideration and confirmation.
Our subjects with DMD showed individual variations in the distribution and extent of deficits on neuropsychological measures, consistent with previous reports in patients with DMD who showed various degrees of intellectual impairment, cognitive deficits, and behavioral abnormalities. 3, 13, 18, 25, 34, 41 A close relationship was found previously between the loss of Dp140 and Dp71 brain dystrophin isoforms and intellectual impairment in DMD, suggesting that the cognitive deficits are very likely the consequences of altered synaptic plasticity, neuronal dysfunction, and cell damage in dystrophin-absent DMD brain tissue. 3, 13, 29, 30 The pattern of glucose hypometabolism detected in our study may suggest links between dysfunction of sensorimotor areas and reduced manual dexterity, 8, 28 temporal cortical areas and cognitive and behavioral impairment, 9,12 as well as cerebellum and intellectual and cognitive deficit. 14, 37 The precise function of dystrophin in cerebral and cerebellar cortical cells and its relation to glucose uptake and metabolism has yet to be elucidated. Dystrophin may transduce molecular signals from the extracellular environment to cell nucleus 29 ; however, it is not known how the impaired signal transduction can lead to abnormal intracellular glucose uptake and metabolism. In neuropathological studies of DMD and mdx mouse there is evidence of neuronal loss and gliosis, as well as abnormal arborization, reduced dendritic length, and altered shape of pyramidal cells. 22, 36 Whether these abnormalities occur during early development as a consequence of aberrant dystrophin expression or are progressive in nature as the disease advances is not clear. It should be pointed out that neither the present nor previous studies 3, 25 revealed progressive mental retardation or other progressive central nervous system symptoms in DMD, which might be expected if there is steady cell damage after birth due to membrane instability that resulted in altered intracellular ion homeostasis. 10, 17, 20 Thus, the abnormalities detected by FDG PET may reflect local cytoarchitectural abnormalities associated with altered neural development, as dystrophin may regulate distinct aspects of neurogenesis, neuronal migration, and cellular differentiation. 29 It will be important, in our subjects, to obtain longitudinal PET data to determine whether hypometabolism is progressive. Finally, postmortem neuropathological correlations with regional cerebral glucose metabolism may further elucidate whether PET studies can localize dystrophin-deficient areas of brain injury in DMD. 
